The mechanism responsible for attenuation of the peak heart rate response to exercise in patients after cardiac transplantation was studied . Because the donor heart is believed to be surgically denervated, the peak heart rate response to exercise is dependent primarily on 1) an increase in the circulating levels of the catecholamines norepinephrine and epinephrine at peak exercise, and ) the end-organ responsiveness of the sinoatrial (SA) node to beta-adrenergic stimulation . To assess the former mechanism, the levels of plasma nonepinephrine and epinephrine were measured at rest and at peak exercise on a cycle ergometer in 3 transplant recipients an average of 7 ± 1 months after transplantation and in 3 normal subjects matched for age . To assess the latter mechanism, the heart rate response to a graded infusion of isoproterenol was determined in six normal subjects with and without atropine pretreatment and in eight transplant recipients .
After orthotopic cardiac transplantation, the heart rate response to exercise is delayed, most likely because of the lack of cardiac innervation (1, ) . In addition, the peak heart rate achieved in response to a maximal exercise effort is also reduced, even years after transplantation (1, ) . In normal subjects, heart rate increases early in exercise because of withdrawal of parasympathetic tone (3) . The further increase in heart rate at maximal exercise effort is dependent on increased sympathetic stimulation of the sinoatrial (SA) node (3) . Thus, in normal subjects, the maximal heart rate achieved with exercise is the consequence of the level of sympathetic stimulation of the heart and the functional In transplant recipients, both the absolute plasma levels of nonepinephrine and epinephrine at peak exercise and the increments from baseline to peak exercise were comparable with or greater than those in normal subjects . In transplant recipients, the isoproterenol dose that increased heart rate by 5 beats/min over baseline was not different from that in atropine-treated normal subjects (normal subjects 9 ± ng/kg per min; transplant recipients 11 ± I ng/kg per min ; p = NS) .
These data show that after cardiac transplantation, there is a normal or slight elevation of circulating catecholamines at peak exercise, and that the responsiveness of the SA node to beta-adrenergic stimulation is normal . Thus, the most likely explanation for the attenuated peak heart rate response to exercise after cardiac transplantation is lack of direct efferent innervation of the SA node . (J Am Coll Cardiol 1989 ; 14:338-44) integrity of the beta-adrenergic receptor pathway in the SA node . After cardiac transplantation, the donor heart is surgically denervated and, therefore, without efferent parasympathetic or sympathetic innervation (1) . Consequently, the heart rate at rest after cardiac transplantation is elevated as a result of the loss of parasympathetic tone, and a further increase in heart rate can be mediated only by an increase in circulating catecholamines (1) .
The mechanism responsible for the reduced peak heart rate response to exercise in patients after orthotopic cardiac transplantation is not known . There are at least three potential mechanisms : 1) a decrease in the rise in circulating catecholamines in response to exercise, ) an abnormality in beta-adrenergic receptor function at the level of the SA node, or 3) a lack of direct cardiac sympathetic innervation as a result of surgical denervation . In this study, the first two of these mechanisms are examined . The adequacy of the circulating catecholamine response to exercise was evaluated by measuring the changes in plasma norepinephrine and epinephrine levels during exercise in 3 patients 7 ± I months after orthotopic cardiac transplantation and in 3 normal subjects who were matched for age . End-organ postsynaptic beta-adrenergic receptor chronotropic sensitivity of the SA node was evaluated by comparing the effect of an intravenous infusion of isoproterenol on heart rate in eight patients after transplantation and six normal subjects of similar age .
Methods
Study groups . Altogether, 31 cardiac transplant recipients and 9 normal subjects were studied . Twenty-three transplant recipients and 3 normal subjects underwent exercise testing (Table 1) . Eight transplant recipients and six normal subjects received a graded isoproterenol infusion (Table ) . All transplant recipients were clinically stable and without histologic evidence of significant rejection at the time of study . Transplant recipients were classified into those studied within 3 months of transplantation ("early recipients" ; n = 11), and those studied more than 3 months after transplantation ("late recipients" ; n = 1 ) . All transplant recipients were receiving prednisone and cyclosporin A, and four of the late recipients were also receiving azothioprine . The mean dose of cyclosporin A was 478 ± 40 mg/day (range 1 0 to 900 ; median 480) . The mean dose of prednisone was 5 mg/day (range 1 to 50 ; median 0 ± ) . Table 3 . Hemodynamic Responses to Exercise in 3 Normal Subjects and 3 Transplant Recipients graphic (ECG) recording, and systolic blood pressure was measured with use of a standard arm cuff mercury sphygmomanometer . Heart rate and systolic blood pressure were recorded at rest, at the end of each work load and at peak exercise . Subjects breathed through a three-way valve mouthpiece connected to a metabolic cart (Sensormedics, Horizon System) that allowed determinations of inspired volumes, expired oxygen (0 ) and carbon dioxide (C0 ) content and respiratory quotient . Oxygen consumption (V0 ) was recorded at rest, at the end of each work load and at peak exercise . Respiratory quotient was recorded at peak exercise . Isoproterenol infusion . An intravenous cannula was inserted into an antecubital vein . After a 30 minute supine rest period, isoproterenol was administered as a continuous infusion by a Harvard pump at increasing rates every 5 min as follows : 5, 10, 15, 0 and 5 ng/kg per min (5, 6) . Heart rate was monitored by means of a continuous ECG recording at 5 mm/min, and systolic and diastolic blood pressures were measured with use of a standard arm cuff mercury sphygmomanometer . Heart rate and blood pressure were recorded at rest and every 5 min during the last full minute of each dose of isoproterenol . Isoproterenol infusion was discontinued if heart rate increased by >35 beats/min or atrial or ventricular ectopic activity developed . Venous blood samples for plasma nonepinephrine and epinephrine were drawn at rest, just before isoproterenol infusion .
Normal subjects received isoproterenol infusions with and without pretreatment with atropine on two different days . Atropine (0 .01 to 0 .0 mg/kg, intravenous bolus) was administered to abolish vagally mediated baroreflex slowing of heart rate secondary to the effect of intravenous isoproterenol to widen pulse pressure (6, 7) . Atropine was administered 3 to 5 min before isoproterenol infusion, and a stable baseline heart rate was obtained for at least min before the administration of isoproterenol .
Data analysis . Data were analyzed with use of nonpaired or paired t tests, as appropriate . When more than two groups *p < 0 .0167 versus normal subjects : tp < 0 .0167 early versus late recipients . NS = not significant ; V0, = oxygen consumption .
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were compared, Bonferroni's method for multiple comparisons was used, such that statistical significance was assumed if the null hypothesis could be rejected at the 0 .05/n probability level, where n = the number of comparisons (8) . The isoproterenol infusion rate that increased heart rate by 5 beats/min over baseline (Iso 5 ) was determined by linear regression analysis (5) . All data are expressed as mean values ± SEM .
Results
Exercise responses of normal subjects and transplant recipients (Table 3 , Fig . 1 ) . Peak exercise work load and oxygen consumption were significantly reduced in both early and late transplant recipients . Early recipients tended to have more impairment than late recipients . An adequate exercise effort was apparent in all three groups, as reflected by mean respiratory quotients of 1 . 3 ± 0 .0 , 1 .10 ± 0 .04 and 1 .10 ± 0 .03 in normal subjects and early and late transplant recipients, respectively .
Heart rate at rest was higher in transplant recipients . Peak exercise heart rate was reduced in transplant recipients, and the increment in heart rate from rest to peak exercise was markedly depressed . The peak exercise increment in heart rate was more depressed in early than in late recipients . Peak exercise systolic blood pressure and double (rate-pressure) product were significantly reduced in both early and late transplant recipients .
Changes in plasma catecholamines with exercise in normal subjects and transplant recipients (Table 4 , Fig . 1 ) . In early transplant recipients, plasma nonepinephrine at rest and during peak exercise and the increment from rest to peak exercise were similar to those in normal subjects . In late transplant recipients, plasma nonepinephrine at rest and peak exercise and the increment from rest to peak exercise were increased compared with those in normal subjects .
Plasma epinephrine at rest was mildly elevated in late transplant recipients . In addition, epinephrine at peak exer- Figure 1 . Heart rate and plasma catecholamine levels at rest and during peak exercise, and the increments from rest to peak exercise in 3 normal subjects (dotted bars) and early and late transplant recipients (hatched bars) . Data are the mean values ± SEM for 3 normal subjects and 11 early and 1 late transplant recipients (described in Table 1 ) . *p < 0.0167 versus normal subjects .
cise and the increment with exercise were not different from those in normal subjects, although both tended to be higher in late recipients . Effects of isoproterenol infusion (Table 5 , Fig . ) . In normal subjects, the isoproterenol infusion rate required to increase heart rate by 5 beats/min (Iso 5) was 19 ± 4 ng/kg per min . At the peak isoproterenol infusion rate, systolic blood pressure increased, diastolic blood pressure decreased and pulse pressure increased substantially by 47 ± 6 mm Hg . It has been shown previously (6) that continuous graded isoproterenol infusion causes significant vagal inhibition of heart rate, presumably because of the effect of an increase in pulse pressure to stimulate baroreflex activity . Because the heart in transplant recipients lacks vagal innervation, it was important to eliminate the influence of vagal tone in normal subjects . Pretreatment with atropine caused an increase in basal heart rate, and was associated with a greater increase in heart rate at each isoproterenol infusion rate (Fig . ) , as reflected by a significant decrease in the IS0 5 to 9 ± ng/kg per min .
In transplant recipients, rest heart rate (88 ± 5 beats/min) was similar to that in atropine-treated normal subjects (93 ± 5 beats/min) . Likewise, the heart rate response to isoproterenol was similar to that in atropine-treated normal subjects, with an Iso, 5 of 11 ± 1 versus 9 ± ng/kg per min in normal subjects .
Discussion
These data confirm that peak exercise capacity is significantly reduced in clinically stable cardiac transplant recipients several months after operation, and they emphasize that there is a substantial attenuation in the peak heart rate response to a maximal exercise effort (1) . This is apparent from the reduction in peak exercise heart rate, and is even more evident when the incremental increase in heart rate with exercise is examined . For instance, heart rate increased by 104 beats/min during exercise in normal subjects, but by only 7 and 44 beats/min, respectively, in patients early and late after cardiac transplantation .
Response of circulating catecholamines to exercise . The primary goal of these studies was to clarify the mechanism responsible for this attenuated peak heart rate response in transplant recipients . Because the heart of these patients is surgically denervated, the local delivery of nonepinephrine to the sinoatrial (SA) node by sympathetic nerves is substantially reduced or completely absent . Therefore, it can be reasonably assumed that beta-adrenergic receptor stimulation of the SA node is solely due to circulating plasma nonepinephrine and epinephrine . In transplant recipients, the peak levels and the incremental increases in nonepineph- rine and epinephrine with exercise were either comparable with or greater than those in normal subjects . Thus, these Figure . The increase in heart rate at rest in response to a continuous graded infusion of isoproterenol in normal subjects (open circles), normal subjects pretreated with atropine (closed circles) and transplant recipients (squares) . Data are mean values ± SEM for six normal subjects and eight transplant recipients (described in Table  ) . Atropine pretreatment in normal subjects caused a significant decrease in the mean 150 5 dose from 19 ± 4 to 9 ± ng/kg per min (p < 0 .0167) . The mean Iso 5 doses in atropine-treated normal subjects and transplant recipients were similar (9 ± and 11 ± 1 ng/kg per min, respectively) . Iso 5 = isoproterenol infusion rate that increased heart rate by 5 beats/min over baseline . data do not suggest an impairment in the circulating catecholamine response to peak exercise . On the contrary, they suggest that the sympathetic response to peak exercise may actually be mildly increased in late transplant recipients . There is relatively little information available regarding the relation between circulating catecholamine levels and heart rate in normal subjects . Recently, Stratton et al . (9) studied the hemodynamic effects of the concurrent infusion of nonepinephrine and epinephrine in atropine-treated normal subjects . This approach achieved plasma norepinephrine and epinephrine levels of 1,78 and 355 pg/ml, respectively, and resulted in an increase in heart rate to 1 7 beats/min . The denervated transplanted heart provides a unique opportunity to evaluate the relation between circulating catecholamine levels and heart rate during exercise . In our study, plasma catecholamines at peak exercise reached levels similar to those achieved by Stratton et al . (9) with intravenous catecholamine infusion, and were associated with a peak heart rate of 11 and 134 beats/min in early and late recipients, respectively . Taken together with the data of Stratton et al . (9) , our observations suggest that the heart rate response to exercise in transplant recipients is commensurate with and probably appropriate for the levels of circulating catecholamines . Presumably, the heart rate response in normal subjects is higher for any given circulating catecholamine level because of the additional effect of direct efferent innervation .
Postsynaptic beta-adrenergic responsiveness . There is substantial in vitro documentation (10-1 ) of an inverse relation between the level of beta-adrenergic receptor stimulation and the responsiveness of the beta-adrenergic receptor pathway . Persistently increased beta-adrenergic stimulation is . Conversely, it has been shown in an animal model of sympathetic cardiac denervation that there is an increase in beta-adrenergic receptor density, which may be associated with supersensitivity to beta-adrenergic agonists (13, 14) . More recently, Yusuf et al . (5) observed that the chronotropic response to isoproterenol infusion in cardiac transplant recipients was increased compared with that in normal subjects . Based on this observation, it was postulated that cardiac transplant recipients would exhibit an increase in beta-adrenergic receptor density (5) .
If postsynaptic beta-adrenergic supersensitivity of the SA node occurred after cardiac transplantation, it might play an important role in compensating for the lack of direct sympathetic efferent nerves to the heart . To assess postsynaptic beta-adrenergic responsiveness in the SA node directly, we evaluated the chronotropic response to graded infusions of isoproterenol . Because the transplanted heart is without direct vagal tone, it was important to block vagal tone in the normal subjects for comparison . Arnold and McDevitt (6) previously showed that isoproterenol administration by the graded continuous infusion method used in this study is associated with increased vagal tone and attenuation of the chronotropic response to isoproterenol in normal subjects . Presumably the increase in pulse pressure stimulates baroreceptors, thereby leading to sympathetic withdrawal and increased vagal tone . As anticipated from the foregoing discussion, in normal subjects, preinfusion of atropine resulted in a significant increase in the chronotropic response to isoproterenol, such that at any given infusion rate of isoproterenol, the heart rate increase was greater with atropine . The chronotropic response to isoproterenol of transplant recipients was similar to that in atropine-treated normal subjects (Fig . ) . Thus, we found no evidence of postsynaptic beta-adrenergic receptor supersensitivity or subsensitivity in transplant recipients . This conclusion is similar to that reached by Gilbert et al . (15) .
A finding of normal beta-adrenergic receptor sensitivity in transplanted hearts is consistent with recent observations (15, 16 ) that beta-adrenergic receptor density is normal or slightly reduced in transplanted human myocardium . Furthermore, Denniss et al . (16) found that the isoproterenolstimulated increments in adenylate cyclase activity are similar in normal and transplanted myocardium . Thus, the biochemical observations in transplanted myocardium are consistent with our physiologic data, and together strongly suggest that the sensitivity of the beta-adrenergic pathway in transplanted human myocardium is normal .
Our conclusion regarding the chronotropic response to isoproterenol infusion in normal subjects differs from that of Yusuf et al . (5), who studied the chronotropic response to a graded isoproterenol infusion without atropine pretreatment . Because in the absence of atropine pretreatment the chronotropic response to isoproterenol in our normal subjects was very similar to that reported by Yusuf et al . (5) (Fig . ) , it appears that the apparent supersensitivity in transplant recipients studied by those investigators may have been due to the effect of vagal tone to attenuate the heart rate response to isoproterenol in normal subjects .
Conclusions . These observations suggest that the attenuated heart rate response to exercise in patients after cardiac transplantation is primarily due to lack of direct sympathetic innervation of the SA node . The circulating catecholamine response to exercise is normal or slightly augmented, and the end-organ response to beta-adrenergic stimulation appears to be normal .
